Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Sano Genetics delivers a comprehensive 360° platform designed for precision medicine and clinical trial research, integrating various aspects such as patient recruitment, genetic testing, informed consent, and ongoing engagement to significantly enhance and streamline study processes. The platform accommodates custom protocol creation and the preparation of ethical submission documents, alongside digital prescreening and consent procedures, as well as recruitment assistance through online marketing efforts, partnerships, and advocacy groups, which allows sponsors and contract research organizations to connect with specific patient populations or those often overlooked in various regions. Additionally, Sano provides convenient, non-invasive saliva-based DNA testing kits that serve as a budget-friendly option compared to traditional clinic blood draws, along with logistical support for sample collection and processing. Their services include dependable genetic and biomarker analysis conducted by accredited laboratories, bioinformatics services, and the return of results, complemented by genetic counseling when necessary, ensuring a holistic approach to patient care and study accuracy. By leveraging technology and community engagement, Sano Genetics is poised to transform the landscape of clinical trials and personalized medicine.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
API Access
Has API
Integrations
Signals Research Suite
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Sano
Founded
2016
Country
United Kingdom
Website
sanogenetics.com
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/